LifeX Announces Portfolio Company NeuBase Therapeutics To Merge with Ohr Pharmaceutical

LifeX CEO Dr. Dietrich Stephan to take over as NeuBase Therapeutics CEO; LifeX names University of Pittsburgh's Dr. Evan Facher as interim CEO PITTSBURGH, Jan. 4, 2019 -- (Healthcare Sales & Marketing Network) -- LifeX™ today announced that its portfol... Biopharmaceuticals, Mergers & Acquisitions, Personnel NeuBase Therapeutics, Ohr Pharmaceutical, LifeX
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news